|
|
Oncology
API
KLab has a dedicated oncology
facility for manufacturing various APIs. KLab also
has a separate sterile powder manufacturing
facility.
|
|
ANTI NEOPLASTIC |
Gefitinib
Tamoxifen Citrate IP/BP (With Open part of DMF)
Oxaliplatin BP
Gemcitabine
Zoledronic Acid (With Open part
of DMF)
Imatinib Mesylate (With Open
part of DMF)
Anastrozole (With Open part of
DMF)
Cisplatin IP/BP/USP (With Open
part of DMF)
Cyclophosphamide (Sterile)
IP/BP/USP (With Open part of DMF)
Cyclophosphamide (Non Sterile)
IP/BP/USP (With Open part of DMF)
Carboplatin BP/USP (With Open
part of DMF)
Hydroxyurea BP/USP (With Open
part of DMF)
Letrozole USP (With Open part of
DMF)
|
|
|
Present
|
 |
|
Introduced Patented Products based on
NDDS
(Marketed in India and out-Licensed for the
Developing Countries)
|
| |
|
Future
|
 |
|
Patents driven
by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to
the developed countries)
|
| |
|
